Follow us on:
Breaking News
May 4, 2026
Breaking News
Breaking News
Allos _ENL_050426_650x90
This Week at Contract Pharma
ECOLAB_Webinar_05-06-26_ThisWeek@

UCB Agrees to Acquire Candid Therapeutics

 
UCB Agrees to Acquire Candid Therapeutics

Expands its capabilities in next-generation biologics with Cizutamig, Candid’s lead investigational asset.
Read More >>

Headlines

Breaking News

Novartis to Add New Facility in Morrisville, NC

The new API facility in North Carolina will enable end‑to‑end manufacturing for all advanced technology platforms in U.S.

SPONSOR

Reduce risk and optimize consistent biomanufacturing growth

Choosing the right cell culture media supplier is critical to quality, consistency, and reliable supply. Learn five key factors to reduce risk and scale.

Breaking News
Collaborations & Alliances

Evotec Nominates Preclinical Development Candidate in Collaboration with Almirall

Joint Evotec–Almirall team advances small molecule program to preclinical development.

Breaking News
Promotions & Moves

Ardena Adds Ben Ash as CFO, Henny Zijlstra as CCO

The appointments impact Ardena’s financial strategy as well as business development and marketing.

SPONSOR

[WEBINAR] Health Chain Orchestration - Is Your Network Working for You or Holding You Back?

In this Contract Pharma webinar on May 19th, sponsored by Marken, explore strategies for resilient healthcare supply chains, from cold chain logistics to real-time visibility and global risk mitigation.

CP-Stream_ContentHub_650x250

Breaking News

Thermo Fisher Scientific Introduces Gibco CTS DynaXS Single Use Bioreactor

Offers a scalable platform from small process development batches to larger cGMP manufacturing runs.

SPONSOR

Pharma’s Lab of the Future is Here

Explore how AI, automation, and personalized medicine are redefining genomics, driving a market projected to reach $80 billion by 2030.

Featured Resources

Solution Content Centers SPOTLIGHT

Thermo Fisher Scientific Pharma Services

Thermo Fisher Scientific serves the pharmaceutical, biotech, and life sciences industries as a strategic contract development and manufacturing organization (CDMO) and clinical services partner. Thermo Fisher’s end-to-end, integrated CDMO capabilities help companies on their drug development and manufacturing journeys. From research and development to regulatory landscape support, supply chain management, and everywhere in between, the company’s services and solutions support the entire life cycle of drug substances and drug products, from preclinical research to commercial manufacturing. Thermo Fisher knows your challenges and has developed solutions you can trust to help bring your treatment to market faster.

 

Solution Center SPOTLIGHT

CMC Pharmaceuticals

CMC Pharma expedites drug product development with flexible lab services tailored to every stage of development. FDA-registered and inspected labs are equipped to conduct both routine & customized drug product development studies to ensure the purity and potency of the finished drug product through product approval and commercialization.